Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by PRKCDBP was identified as a binding protein of the protein kinase C, delta (PRKCD). Additionally we are shipping Protein Kinase C, delta Binding Protein Proteins (5) and Protein Kinase C, delta Binding Protein Kits (4) and many more products for this protein.
Showing 10 out of 56 products:
Human Polyclonal PRKCDBP Primary Antibody for EIA, WB - ABIN360096
Zöchbauer-Müller, Fong, Geradts, Xu, Seidl, End-Pfützenreuter, Lang, Heller, Zielinski, Gazdar, Minna: Expression of the candidate tumor suppressor gene hSRBC is frequently lost in primary lung cancers with and without DNA methylation. in Oncogene 2005
Show all 3 references for ABIN360096
Human Polyclonal PRKCDBP Primary Antibody for ELISA, WB - ABIN566689
Bai, Deng, Li, Wang, An, Deli, Gao, Xie, Dai, Cong: Down-regulation of the cavin family proteins in breast cancer. in Journal of cellular biochemistry 2011
Cow (Bovine) Polyclonal PRKCDBP Primary Antibody for EIA, WB - ABIN401663
McMahon, Zajicek, Li, Peyton, Minna, Hernandez, Luby-Phelps, Anderson: SRBC/cavin-3 is a caveolin adapter protein that regulates caveolae function. in The EMBO journal 2009
Rather than forming a single coat complex containing the three cavin (show PTRF Antibodies) family members, single-molecule analysis reveals an exquisite specificity of interactions between cavin1 (show PTRF Antibodies), cavin2 (show SDPR Antibodies) and cavin3.
cavin3 is recruited to the caveolae coat by cavin1 (show PTRF Antibodies) to interact with caveolin1 and regulate the duration time of caveolae at the plasma membrane.
in vivo consequences of cavin-3 knockout are increased lactate production and cachexia
These results demonstrate that mucosal expression of PRKCDBP correlated strongly with TNF-alpha (show TNF Antibodies) expression in UC patients and that infliximab therapy resulted in profound reductions in both PRKCDBP and TNF-alpha (show TNF Antibodies).
we found loss at 11p15 to be a marker for triple-negative breast cancer and breast cancer brain metastases and PRKCDBP to be a potential target gene in this locus.
individuals with the variant homozygous CC genotype of PRKCDBP rs1051992 were at higher risk for developing endometrial cancer, but this genotype was a favorable prognostic factor once cancer was present
The cavin (show PTRF Antibodies) family protein Polymerase 1 and transcript release factor, SRBC (show CD2 Antibodies) and serum deprivation response protein (show SDPR Antibodies) were down regulated in breast cancer cell lines and breast tumor tissue.
Data indicate that PRKCDBP expression was hardly detectable in 29 of 80 (36%) primary tumors and 11 of 19 (58%) cell lines.
Our data demonstrate that epigenetic inactivation of hSRBC due to aberrant promoter hypermethylation is a common event and might be implicated in human ovarian tumorigenesis.
Data show low or moderate methylation was found in seven selected genes BAD, BBC3 (show BBC3 Antibodies), CAV1 (show CAV1 Antibodies), CDK2AP1 (show CDK2AP1 Antibodies), NPM1 (show NPM1 Antibodies), PRKCDBP and THEM4 (show THEM4 Antibodies).
The protein encoded by this gene was identified as a binding protein of the protein kinase C, delta (PRKCD). The expression of this gene in cultured cell lines is strongly induced by serum starvation. The expression of this protein was found to be down-regulated in various cancer cell lines, suggesting the possible tumor suppressor function of this protein.
protein kinase C, delta binding protein
, protein kinase C delta-binding protein
, sdr-related gene product that binds to c-kinase
, serum deprivation response factor-related gene product that binds to C-kinase
, D3T-inducible gene 2 protein
, PKC-delta binding protein
, dithiolethione-inducible gene 2 protein
, dithiolethione-inducible gene-2
, sdr-elated gene product that binds to c-kinase